SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001439222-24-000058
Filing Date
2024-03-07
Accepted
2024-03-07 18:49:02
Documents
1
Period of Report
2024-03-05

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1709855334.html 4  
1 FORM 4 wk-form4_1709855334.xml 4 5558
  Complete submission text file 0001439222-24-000058.txt   7094
Mailing Address JOHNSON & JOHNSON ONE JOHNSON & JOHNSON PLAZA NEW BRUNSWICK NJ 08933
Business Address
Foster-Cheek Kaye I (Reporting) CIK: 0001312622 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36014 | Film No.: 24731865

Mailing Address 88 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 88 SIDNEY STREET CAMBRIDGE MA 02139 617-649-8600
AGIOS PHARMACEUTICALS, INC. (Issuer) CIK: 0001439222 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)